Director/PDMR Shareholding

RNS Number : 1891W
Chemring Group PLC
30 July 2018
 

30 July 2018

 

Chemring Group PLC

 

Grant of options

 

 

Chemring Group PLC ("Chemring" or "the Company") announces that it has today granted, pursuant to The Chemring Group 2018 UK Sharesave Plan, options over 16,853 1p ordinary shares in the capital of the Company to Michael Ord, a director of the Company. The options will be exercisable in five years time at an exercise price of 178p per share. 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Michael Ord

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Options over 1p ordinary shares

 

 

 

GB00B45CX44

b)

 

Nature of the transaction

 

 

Grant of options under The Chemring Group 2018 UK Sharesave Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

178p

 

16,853

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

30 July 2018

f)

 

Place of the transaction

 

 

UK

 

 

For further information:

 

Chemring Group PLC

 

Sarah Ellard

Group Legal Director

+44 (0)1794 833 901

     

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFFFDLIIVIT
UK 100

Latest directors dealings